W-L Zhang
Overview
Explore the profile of W-L Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
110
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Duan Y, Ding Z, Cui Z, Song W, Zhang W, Chen A
Eur Rev Med Pharmacol Sci
. 2024 Jan;
28(1):327-335.
PMID: 38235883
Objective: During menopause, women are more likely to develop coronary heart disease (CHD) due to the significant changes in body metabolism brought on by the loss of estrogen. The purpose...
2.
Chen G, Zhang W, Zhang S, Tang K, Zhang Y
Eur Rev Med Pharmacol Sci
. 2023 Jun;
27(10):4536-4543.
PMID: 37259735
Objective: The study aimed at elucidating the role of FOXD2-AS1 in facilitating the malignant progression of hepatocellular carcinoma (HCC) by regulating TWIST1. Patients And Methods: Relative levels of FOXD2-AS1 and...
3.
Wang Q, Yang Z, Zhang W, Li Q, Kang P
Eur Rev Med Pharmacol Sci
. 2022 Oct;
26(18):6536-6549.
PMID: 36196702
Objective: The aim of our study was to determine whether abnormal hyperplasia of chondrocytes occurs in glucocorticoid-induced osteonecrosis of the femoral head (GC-ONFH) using a well-established rat model. Materials And...
4.
Arai Y, Kuroda K, Nomoto T, Tin Z, Sakuragi S, Bareille C, et al.
Nat Mater
. 2022 Feb;
21(4):410-415.
PMID: 35145257
Rare-earth intermetallic compounds exhibit rich phenomena induced by the interplay between localized f orbitals and conduction electrons. However, since the energy scale of the crystal-electric-field splitting is only a few...
5.
Tian M, Li Y, Zheng W, Liu Q, Zhang X, Liu J, et al.
Eur Rev Med Pharmacol Sci
. 2021 Apr;
25(6):2567-2576.
PMID: 33829443
Objective: In previous studies, PCAT1 has been proved to be a key carcinogenic driver in hepatocellular carcinoma. However, the regulatory mechanism of PCAT1 remains poorly understood in diffuse large B-cell...
6.
Wang Y, Jiang X, Feng Z, Li X, Zhang W
Eur Rev Med Pharmacol Sci
. 2021 Feb;
25(3):1164.
PMID: 33629282
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "Long noncoding RNA PCAT-1...
7.
Liu Y, Zhang W, Gu J, Sun Y, Cui H, Bu J, et al.
Eur Rev Med Pharmacol Sci
. 2020 Jul;
24(12):7039-7050.
PMID: 32633398
Objective: Atherosclerosis (AS) is a leading disease with high mortality and morbidity in the world. It has been demonstrated that exosomes can transfer some miRNAs or proteins to regulate the...
8.
Fan C, Yan X, Tian M, Zhang S, Liu J, Sheng Y, et al.
Eur Rev Med Pharmacol Sci
. 2020 Jun;
24(11):6219-6227.
PMID: 32572888
Objective: To explore whether long non-coding RNA nuclear enriched abundant transcript 1 (lncRNA NEAT1) could regulate Hodgkin's lymphoma (HL) cell proliferation and invasion through miR-448, which could target doublecortin like...
9.
Wang Y, Jiang X, Feng Z, Li X, Zhang W
Eur Rev Med Pharmacol Sci
. 2019 Sep;
23(17):7350-7355.
PMID: 31539121
Objective: The role of long noncoding RNAs (lncRNAs) is vital in tumor progression. Our study aims to identify the role of PCAT-1 in the metastasis of pancreatic cancer. Patients And...
10.
Chen D, Richard P, Song Z, Zhang W, Wu S, Jiao W, et al.
J Phys Condens Matter
. 2015 Nov;
27(49):495701.
PMID: 26595404
We have performed polarized Raman scattering measurements on the newly discovered superconductor Ta4Pd3Te16 (T(c) = 4.6 K). We observe 28 out of 33 Raman active modes, with frequencies in good...